JILLIAN GLADD: Open Payments
NPI 1023456449 · CRANBERRY TOWNSHIP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 92 payments from 8 companies in 2025. Trend: 2023 $1,445 · 2024 $1,057 · 2025 $1,299
Food & beverage: $1,192Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $423 |
| Janssen Biotech, Inc. | 22 | $205 |
| GENZYME CORPORATION | 12 | $178 |
| Regeneron Healthcare Solutions, Inc. | 10 | $157 |
| Galderma Laboratories, L.P. | 2 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Amgen Inc. | 3 | $67 |
| UCB, Inc. | 1 | $20 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, NEMLUVIO, COSENTYX, OTEZLA, Rhapsido, AKLIEF.
Industry payments across PA — which companies pay providers there.
